The major objectives of our research program are (1) to identify and characterize the gene products of the newly identified oncogene c-kit, (2) to determine how a modified version of this gene v-kit has acquired transforming activity, and (3) to characterize oncogenes in new FeSV strains. The HZ4-FeSV is a new acute transforming feline retrovirus we have recently shown to contain a unique oncogene v-kit. The transforming protein of this virus is a gag-kit fusion protein. The predicted amino acid sequence of v-kit displays features characteristic of tyrosine specific protein kinases, v-fms being its closest relative. c-fms is known to be homologous with the gene specifying the CSF-1 receptor. Because of the close relationship of v-kit with v-fms and PDGFR, we predict that the c- kit gene product is a receptor which is functionally related to the CSF-1 receptor. To gain a deeper understanding of transformation mediated by transmembrane receptor oncogenes a structural and functional analysis of c-kit and v-kit in which similar and dissimilar features of v-kit and v-fms and c-kit and c-fms will be exploited is proposed. In our proposed structural and functional studies of the c-kit gene products we will investigate the expression of c-kit RNA and in order to determine the primary structure of c-kit we will molecularly clone a c-kit cDNA. We will construct a retrovirus expression vector containing the c-kit cDNA in order to investigate the function and significance of domains in c-kit as they relate to transformation by v-kit. By using kit specific antibodies which will be obtained as part of this proposal we will identify and characterize the c-kit protein product(s). Our studies on v-kit mediated transformation will include: the characterization of enzymatic activities associated with the gag- kit protein; investigations of the significance of membrane association of the gag-kit protein in transformation, the significance of c-terminal sequences in v-kit transformation, and the significance of the kit-specific middle domain in transformation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA032926-05
Application #
3170790
Study Section
Virology Study Section (VR)
Project Start
1983-05-01
Project End
1990-12-31
Budget Start
1989-01-24
Budget End
1989-12-31
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Vosseller, K; Stella, G; Yee, N S et al. (1997) c-kit receptor signaling through its phosphatidylinositide-3'-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane ruffling. Mol Biol Cell 8:909-22
Lerner, N B; Nocka, K H; Cole, S R et al. (1991) Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 77:1876-83
Nocka, K; Tan, J C; Chiu, E et al. (1990) Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J 9:1805-13
Tan, J C; Nocka, K; Ray, P et al. (1990) The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247:209-12
Majumder, S; Ray, P; Besmer, P (1990) Tyrosine protein kinase activity of the HZ4-feline sarcoma virus P80gag-kit-transforming protein. Oncogene Res 5:329-35
Huang, E; Nocka, K; Beier, D R et al. (1990) The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225-33
Nocka, K; Buck, J; Levi, E et al. (1990) Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J 9:3287-94
Manova, K; Nocka, K; Besmer, P et al. (1990) Gonadal expression of c-kit encoded at the W locus of the mouse. Development 110:1057-69
Nocka, K; Majumder, S; Chabot, B et al. (1989) Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3:816-26
Qiu, F H; Ray, P; Brown, K et al. (1988) Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 7:1003-11

Showing the most recent 10 out of 16 publications